Metro Healthcare Indonesia Past Earnings Performance
Past criteria checks 0/6
Metro Healthcare Indonesia's earnings have been declining at an average annual rate of -53.4%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 8% per year.
Key information
-53.4%
Earnings growth rate
-39.4%
EPS growth rate
Healthcare Industry Growth
14.1%
Revenue growth rate
8.0%
Return on equity
-2.9%
Net Margin
-29.0%
Last Earnings Update
30 Sep 2024
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Metro Healthcare Indonesia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
IDX:CARE Revenue, expenses and earnings (IDR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Sep 24
308,717
-89,386
118,646
0
30 Jun 24
301,357
-116,151
124,651
0
31 Mar 24
271,522
-100,908
117,288
0
31 Dec 23
242,681
-110,920
116,322
0
30 Sep 23
260,242
-104,612
126,190
0
30 Jun 23
254,536
-81,944
126,082
0
31 Mar 23
251,761
-104,203
139,036
0
31 Dec 22
260,426
-93,544
145,821
0
30 Sep 22
230,153
-92,420
134,030
0
30 Jun 22
257,336
-61,350
132,219
0
31 Mar 22
278,751
-25,135
127,914
0
31 Dec 21
290,934
6,099
121,607
0
30 Sep 21
289,799
21,958
128,494
0
30 Jun 21
258,201
23,746
125,317
0
31 Mar 21
234,686
24,829
118,894
0
31 Dec 20
216,296
14,313
113,605
0
30 Sep 20
198,330
8,811
97,615
0
30 Jun 20
214,832
-3,907
95,010
0
31 Mar 20
186,776
-17,929
79,605
0
31 Dec 19
154,077
-24,205
64,439
0
31 Dec 18
87,209
-27,487
38,279
0
31 Dec 17
31,198
-11,519
12,842
0
Quality Earnings: CARE is currently unprofitable.
Growing Profit Margin: CARE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CARE is unprofitable, and losses have increased over the past 5 years at a rate of 53.4% per year.
Accelerating Growth: Unable to compare CARE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CARE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.7%).
Return on Equity
High ROE: CARE has a negative Return on Equity (-2.94%), as it is currently unprofitable.